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Abstract
The high use of antibiotics for the treatment of bacterial diseases is one of the main prob-
lems in the mass production of animal protein. Salmon farming in Chile is a clear example of
the above statement, where more than 5,500 tonnes of antibiotics have been used over the
last 10 years. This has caused a great impact both at the production level and on the envi-
ronment; however, there are still few works in relation to it. In order to demonstrate the
impact of the high use of antibiotics on fish gut microbiota, we have selected four salmon
farms presenting a similar amount of fish of the Atlantic salmon species (Salmo salar), rang-
ing from 4,500 to 6,000 tonnes. All of these farms used treatments with high doses of antibi-
otics. Thus, 15 healthy fish were selected and euthanised in order to isolate the bacteria
resistant to the antibiotics oxytetracycline and florfenicol from the gut microbiota. In total, 47
bacterial isolates resistant to florfenicol and 44 resistant to oxytetracycline were isolated,
among which isolates with Minimum Inhibitory Concentrations (MIC) exceeding 2048 μg/mL
for florfenicol and 1024 μg/mL for oxytetracycline were found. In addition, another six differ-
ent antibiotics were tested in order to demonstrate the multiresistance phenomenon. In this
regard, six isolates of 91 showed elevated resistance values for the eight tested antibiotics,
including florfenicol and oxytetracycline, were found. These bacteria were called “super-
resistant” bacteria. This phenotypic resistance was verified at a genotypic level since most
isolates showed antibiotic resistance genes (ARGs) to florfenicol and oxytetracycline. Spe-
cifically, 77% of antibiotic resistant bacteria showed at least one gene resistant to florfenicol
and 89% showed at least one gene resistant to oxytetracycline. In the present study, it was
demonstrated that the high use of the antibiotics florfenicol and oxytetracycline has, as a
consequence, the selection of multiresistant bacteria in the gut microbiota of farmed fish of
the Salmo salar species at the seawater stage. Also, the phenotypic resistance of these bac-
teria can be correlated with the presence of antibiotic resistance genes.
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The phenomenon of antibiotic resistance is, according to the General Assembly of the United
Nations, a priority topic for human development, being on par with global warming [1]. The
number of bacteria resistant to all known antibiotics increases each day, and some have pre-
dicted that by 2050, humanity may return to an era without antibiotics [2]. Antibiotics are not
limited to medical applications in humans; in fact, notable quantities are used in farm animals
and agricultural crops [3,4]. The aims of such usage are to prevent or cure infectious diseases,
as well as to promote livestock/crop growth [5]. The issue of antibiotic resistance is further
aggravated by climate change, which has accelerated the global food crisis. On this point, esti-
mates indicate that if food production does not improve within the next 40 years, the world
will witness a serious global food shortage [6]. Aquaculture is one of the most promising alter-
natives for efficiently and sustainably increasing the production of animal proteins [7]. Never-
theless, farmed fish are not exempt from antibiotics use. By contrast, antibiotics are routinely
administered in aquaculture farms to treat a range of diseases [8]. Antibiotic usage in this
industry is largely uncontrolled, and measures must be enacted to prevent consequent harm to
human health and the environment [9].
Considering the current and projected situation, antibiotic resistance must be addressed
not only from perspectives of human health, but also with considerations to veterinary health
and the impact that the use and liberation of antibiotic substances may have on the environ-
ment [10]. To this end, the “one-health” concept was developed [9,11] to promote multidisci-
plinary and multiarea research on antibiotics resistance. One of the principal concerns that
arose out of this new investigative paradigm was that of commercial producers of animal pro-
teins [12]. Chile, as the second largest worldwide producer of farmed salmon after Norway
[13], has evidenced particular interest in addressing antibiotic resistance in salmon farms.
The Chilean salmon industry is constantly affected by bacterial, parasitic, fungal, and viral
infections that cause a series of diseases, many of which can result in the death of millions of
fish and, consequently, significant production losses [14]. Without doubt, the pathogen that
has mostly plagued the salmon industry over the last 30 years is the facultative intracellular
bacterium Piscirickettsia salmonis, which is the causative agent of salmonid rickettsial syn-
drome (SRS) [15]. This bacterium is responsible for more than 80% of fish deaths occuring
due to infectious diseases in the three principal fish species farmed in Chile, i.e., Atlantic
salmon (Salmo salar), coho salmon (Oncorhynchus kisutch), and rainbow trout (O. mykiss)
[16]. Although this pathogen is present in other salmonid-producing countries, such as Nor-
way [17], Canada [17,18], Scotland, Ireland [17], and Australia [19], this bacterium is much
more aggressive in Chile due to certain genetic traits [15,20]. Although P. salmonis is the pri-
mary pathogen in the Chilean salmon farming, none of the 40 commercially available vaccines
are sufficiently effective at protecting against disease [21–24]. Consequently, antibiotics are the
primary tool employed in controlling this bacterium, meaning that, over the past 40 years,
large quantities of antibiotics have been used by fish farms.
According to a report by the National Fisheries Service (Sernapesca), the salmon industry
used more than 5,500 tons of antibiotics between 2007 and 2017, with each ton of produced
salmon receiving, on average, 500 g of antibiotics [25]. Antibiotics are mostly used during the
fattening stage in marine sites. The two most administered antibiotics in this industry are flor-
fenicol and oxytetracycline, both broad spectrum antibiotcs. In just 2017, 393,9 tons of antibi-
otics were used, 92,2% of which was florfenicol, and 6,7% of which was oxytetracycline. The
remaining 1% corresponded to antibiotics such as erythromycin and amoxycillin [25].
Antibiotics in the aquaculture industry are administered through medicated feed, immer-
sion baths, or, in extreme circumstances, through an intramuscular or intraperitoneal
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injection [26,27]. Medicated feed is not fully digested by fish and, in many cases, is in fact
poorly digested and metabolized, with the consequence being a constant liberation of antibi-
otic substances into the environment [28]. Without doubt, medicated feed also fundamentally
affects the intestinal microbiota of fish [29]. Constant exposure to antibiotic substances leads
to the selection of resistant bacteria and an increase in the horizontal transfer of antibiotic-
resistance genes (ARGs) [30]. This situation ultimately means that the feces of medicated-feed
fish are rich in ARGs.
The primary aim of this study was to characterize the antibiotic-resistant bacteria present in
the intestinal microbiota of farmed Atlantic salmon treated with high antibiotic doses. Four
salmon farms were sampled, and different antibiotic-resistant bacteria were recorded at each.
Specific genetic elements involved in resistance to florfenicol and oxytetracycline were identi-
fied, as were integron elements. This paper establishes a clear relationship between the use of
antibiotics, the presence of resistant bacteria and the high prevalence of antibiotic resistance
genes in the intestinal-microbiota system from the Atlantic Salmon. Additionally, which could
be an important source for the dispersion and liberation of ARGs into the environment, with
potential impacts for human health.
Materials and methods
Sample collection
Four salmon farms located in the Ayse´n Region, in the Cupquelan Fjord (Northern Patagonia,
Chile) were assessed. The farms were chosen for four fundamental characteristics: (i) all the
farms contain fish of the Salmo salar species in a similar period of the productive cycle; (ii)
similar mass of fish (between 4500 and 6000 tons); (iii) all the farms had more than one out-
break of SRS in the productive cycle; and (iv) the four farms had more than one treatment
with medicated food at the time of sampling. (Table 1).
Isolation of bacteria from intestinal fish microbiota
In order to obtain the largest number of bacterial isolates, two sources were used: (i) fecal mat-
ter; and (ii) the intestines. For this, 15 apparently healthy (i.e., no clinical signs of SRS) Atlantic
salmon were randomly selected from each salmon farm. Fecal matter was obtained by applying
perianal stimulation to the fish. Prior to fecal extraction procedure fish were anesthetized with
benzocaine (25 μg/mL). The collected fecal samples from three individuals were pooled, stored
in a 5 mL saline solution (0.85% NaCl), and kept on ice until laboratory analyses 24 h later. To
collect the intestine samples, the animals were euthanized by immersion in a solution of 50
mg/L of benzocaine. The intestines of three fish were also pooled. This study was carried out
in accordance with law 20,380 regarding animal welfare, as set out by the Chilean Health Min-
istry in the use of wild or protected animal species in biomedical research and approved by the
National Fisheries Service (SERNAPESCA) and the Pontificia Universidad Cato´lica de Valpa-
raı´so Bioethical Committee.
Table 1. Number of florfenicol (FLO) and oxytetracycline (OTC) oral treatments, sum of the amount of medi-
cated feed with antibiotics and total fish weight in each Atlantic salmon farm at the time that sampling.
Farm No. treatments and types Amount of medicated feed
with antibiotics (in kg)
Total weight of fish (in tons)
I 3 FCL + 1 OTC 725 5,904
II 4 FCL 807 4,512
III 1 FCL 55 5,262
IV 3 FCL 283 5,578
https://doi.org/10.1371/journal.pone.0203641.t001
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To obtain the bacterial isolates, homogenates were obtained from the pooled fecal matter
and intestines. A dilution series was applied, where 10−4 and 10−5 dilutions (100 μL) were
seeded in sextuplet on tryptic soy agar plates (TSA) (Difco, USA). Plates were incubated at
25˚C, 30˚C, and 37˚C for 48 h and at 15˚C for 72 h, the aim of which being to assess the widest
temperature range possible. TSA medium and incubation temperature have been commonly
used to isolate bacteria from fish microbiota [31–33]. To prevent fungus and yeast growth, a
50 μg/mL concentration of cycloheximide was added as an antifungal agent.
Construction of a bank of bacterial isolates
Colonies grown in TSA medium were classified according to standard patterns: shape, color,
texture and shape of the colony-border. Each of the differentiated colonies was seeded in
96-well plates in TSB medium and grown at the temperature at which it was isolated, regard-
less of whether it came from intestine or fecal material. In order to ensure the purity of the iso-
lates, each of the colonies grown in TSB medium were Gram-characterized and the mixed
cultures or cultures contaminated with yeasts were discarded.
Determinations of minimum inhibitory concentration (MIC)
The MICs for all the bacterial isolates were determined following the agar double-dilution pro-
tocol established by the Clinical and Laboratory Standards Institute[34,35]. Briefly, each MIC
was estimated by inoculating square plates (120 mm2) with the Mu¨ller-Hinton medium
(Sigma-Aldrich, USA) and increasing concentrations of florfenicol and oxytetracycline (0–
2,048 μg/mL), using a 96 pin replicator (Boekel 140500). As a control was used the strain E.
coli K12. Once the MIC of each isolate was calculated, those isolated showing a MIC 128 μg/
mL for florfenicol and 64 μg/mL for oxytetracycline were considered to be resistant bacteria,
according to EUCAST clinical standard [36]. Finally, two banks of resistant bacteria were cre-
ated–a florfenicol-resistant bank (FB) and an oxytetracycline-resistant bank (OB)
Determination of the multiresistant phenotype
The cross-resistance potentials of isolates from both banks (i.e., FB and OB) were measured by
estimating MICs to treatment with chloramphenicol (CHL), tetracycline (TET), ciprofloxacin
(CYP), erythromycin (ERY), ampicillin (AMP), and kanamycin (KAN). The previously
described methodology for establishing MICs was applied, using increasing concentrations of
each antibiotic (0–2,048 μg/mL). Resistance levels was defined by the EUCAST values for any
antibiotic in E. coli K12: AMP 64 μg/mL, CHL 32 μg/mL, CIP 4 μg/mL, ERY 16 μg/
mL, KAN 16 μg/mL and TET 32 μg/mL [36]
Molecular identification of resistant bacteria
To identify the resistant isolates, 16S rRNA gene sequencing analysis was used for taxonomic
classification. Genomic DNA extracts were obtained with Chelex-100 (Bio-rad, USA) accord-
ing to manufacturer instructions. PCR amplification of the 16S gene was carried out using the
universal primers 27F (5'-AGAGTTTGATCMTGGCTCAG-3’) and 1492R (5’-GGTTACCT
TGTTACGACTT-3’). The amplification conditions were as follows: initial denaturalization at
95˚C for 3 min, followed by 35 cycles at 95˚C for 45 s, 55˚C for 30 s, and 72˚C for 1 min, with
final extension at 72˚C for 5 min. The obtained sequences were analyzed using the BLAST tool
[37], with comparisons conducted against sequences available in GenBank (NCBI). Five
rounds of amplification and sequenciation were used to verify the sequences. The obtained
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16S rRNA sequences for each resistant bacterial isolate were submitted to the GenBank data-
base (S1 Table).
Characterizing genetic determinants of resistance
The incidences of genetic determinants implicated in resistance to florfenicol and oxytetracy-
cline were evaluated through PCR and sequencing of the most relevant genes described in rela-
tion to antibiotic resistance. The partial sequences of the genes (three or four for fish farm)
were submitted to the GenBanK database (S2 Table). For florfenicol, these genes included floR
[38,39], fexA [40,41], and cfr [42]. For oxytetracycline, these genes included tetA, tetB, tetE,
tetL, tetH, tetM, tet34, and tet35 [43]. The primers used for each gene are given in Table 2. All
primers were validated with the NCBI primer-Blast tool before their use.
Statistical data analysis
Statistical analyses were performed using SPSS 22.0 for Windows (Chicago, IL). The preva-
lence of antibiotic resistance bacteria and antibiotic resistance genes was compared among
Table 2. Primers, amplicon size (base pairs [bp]), annealing temperatures (˚ C), and references for amplified PCR products.
Primer Sequence Annealing Gene descriptionPF Source Length
Temperature
27 F 5’-AGAGTTTGATCMTGGCTCAG-3’ 58˚C 16S rDNA Universal 1460 bp
1492 R 5’-GGTTACCTTGTTACGACTT-3’
floR F 5'-CCGTCATTCCTCACCTTCAT-3' 58˚C floRMFS efflux pump This study 408 bp
floR R 5'-GACAAGGGAAATGAGCGGTA-3'
fexA F 5'-TTTCGCTGTTCTTGTGTTCG-3' 56˚C fexA MFS efflux pump This study 358 bp
fexA R 5'-ACCTTGGAAAATCCCCATTC-3'
cfr F 5'-TGAAGTATAAAGCAGGTTGGGAGTCA-3' 62˚C cfr RNAr metiltransferase This study 746 bp
cfr R 5'-ACCATATAATTGACCACAAGCAGC-3'
tetL F 5'-TTATCGTTAGCGTGCTGTCATTCC-3' 60˚C tetL MFS efflux pump Miranda et al., (2003) 450 bp
tetL R 5'-TTAAGCAAACTCATTCCAGC-3'
tetH F 5'-ATACTGCTGATCACCG-3' 56˚C tetH MFS efflux pump Miranda et al., (2003) 135 bp
tetH R 5'-TCCCAATAAGCGACGC-3'
tet34 F 5'-ATGAAAACGAACGCTAATTAACCA-3' 60˚C tet34 tetracycline resistance gene Miranda et al., (2003) 270 bp
tet34 R 5'-ACATAGAGATCGATGCTAGTACTA-3'
tet35 F 5'-ATGCGCAAGACCGTCCTAC-3' 60˚C tet35 MFS efflux pump Miranda et al., (2003) 700 bp
tet35 R 5'-CACACACTAGTAACGGTCGAA-3'
tetA F 5'-GCGCGATCTGGTTCACTCG -3' 60˚C tetA MFS efflux pump This study 164 bp
tetA R 5'- AGTCGACAGYRGCGCCGGC-3'
tetB F 5'-TACGTGAATTTATTGCTTCGG-3' 58˚C tetB MFS efflux pump This study 206 bp
tetB R 5'-ATACAGCATCCAAAGCGCAC-3'
tetE F 5'-GTTATTACGGGAGTTTGTTGG-3' 58˚C tetE MFS efflux pump This study 213 bp
tetE R 5'-AATACAACACCCACACTACGC-3'
tetM F 5'-GTGGACAAAGGTACAACGAG-3' 58˚C tetM tetracycline resistance gene This study 406 bp
tetM R 5'-CGGTAAAGTTCGTCACACAC-3'
int1 F 5'-CAGTGGACATAAGCCTGTTC-3' 59˚C Class 1 integrase This study 160 bp
int1 R 5'-CCCGAGGCATAGACTGTA-3'
PF: Partial fragment of the gene
https://doi.org/10.1371/journal.pone.0203641.t002
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isolates from different origins or taxonomic groups using the chi-square test at a significance
level of 0.05.
Results
Characterization of the bacterial isolates bank
More than 12,000 colonies were obtained in the TSA plates without antibiotics from the four
farms sampled. Of these colonies, 28% was obtained at 15˚C, while 63% of the isolates came
from the growth at 25˚C. Finally only 9% of the colonies came from the growth at 30˚C. In
none of the fish farms were bacteria found that could grow at 37˚C. After the classification of
the colonies according their pattern of size, shape, color, texture and the shape of the border,
and after discarding the mixed cultures or those contaminated with yeast, the number of colo-
nies was considerably reduced: 2,628 coming from the intestine and 2,390 colonies from the
feces, showing no differences between this two different sources. The individual analysis per
farm showed that 1,248 colonies were obtained from the farm I; while 1,035 are from farm II;
1,472 from farm III; and 1263 from farm IV. The amount and diversity of the patters of size,
shape, texture, color and shape of the border from the colonies were similar for the four farms.
Determinations of MICs for all isolates of the bacterial bank
The MICs to florfenicol or oxytetracycline were determined using microdilutions in Mu¨ller-
Hinton agar, adding increasing concentrations (0–2,048 μg/mL) of each antibiotic for all iso-
lates of the bacterial bank. Once MICs were determined, those isolates evidencing resistance to
64 μg/mL for oxytetracycline or128 μg/mL for florfenicol were classified as resistant. A
total of 47 (23 from feces and 24 from intestine) florfenicol-resistant and 44 (21 from feces and
23 from intestine) oxytetracycline-resistant isolates were classified (Figs 1 and 2).
Of the bacteria resistant to florfenicol, 93.6% presented a MIC >256 μg/mL, and 38.2% of
these isolates had a MIC > 1,024 μg/mL. Of the bacteria resistant to oxytetracycline, 56.8%
presented an MIC >256 μg/mL, and 34.1% of this group had an MIC of 1,024 μg/mL. These
findings suggest a high degree of resistance in bacteria from the gut microbiota of fish fed with
medicated feed containing these antibiotics. Even at the three farms where medicated food did
not contain oxytetracycline, high MICs against this antibiotic were found.
With this data the Antibiotic Resistance Rate (ARR) (resistant bacteria/total culturable bac-
teria) was calculated, and for the florfenicol resistance samples this rate was estimated in
9.4x10-3 and 8.7x10-4 for the oxytetracycline resistance samples. In other words, less than 1%
of the total isolates were classified as resistant bacteria. If this value is analyzed by farm and by
resistant bank, it can be seen that farm I shows a value of 8x10-3, while farm II shows a value of
1.2x10-2, and farms III and IV show values of 7.4x103 and 7.9x10-3 respectively flor florfenicol.
In this case the farm II shows an antibiotic resistance rate almost two times higher compared
with the others three farms. This results could be explained by the amount of florfenicol treat-
ment used in the farm II. In the case of the OB the values are the following: Farm I: 1.4 x10-2;
farm II 9.6x10-3; farm III 4,7x10-3; and farm IV 7.1x10-3. In this case it is the farm II that has a
value almost two times higher compared to the rest of the farms, which could be explained as
it is the only farm where oxytetracycline is used as a treatment in seawater.
Multiresistant bacterial isolates to florfenicol and oxytetracycline
To estimate the multiresistance capacity against other antibiotics in strains classified as resis-
tant to florfenicol and/or oxytetracycline (i.e., MIC64 μg/mL for oxytetracycline or
128 μg/mL for florfenicol), MIC values were determined against the following antibiotics:
Isolation and characterization of multiresistant bacteria from farmed salmon gut
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Fig 1. Minimum inhibitory concentrations (MIC) in bacteria resistant to florfenicol. (μg/mL).
https://doi.org/10.1371/journal.pone.0203641.g001
Fig 2. Minimum inhibitory concentrations (MIC) in bacteria resistant to oxytetracycline. (μg/mL).
https://doi.org/10.1371/journal.pone.0203641.g002
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chloramphenicol, tetracycline, erythromycin, ampicillin, ciprofloxacin, and kanamycin.
Among the FB resistant isolates, 4.3% showed resistance phenotype to the eight assessed anti-
biotics, and 57.3% showed resistance to at least four antibiotics (Table 3). Different results
were found for OB resistant bacteria, with a 8.5% of the bacterial isolates showed resistance to
the eight antibiotics. Nevertheless, 100% of OB-classified isolates were resistant to at least four
of the tested antibiotics (Table 4). These findings evidence a clear selection tendency for multi-
resistant bacteria when florfenicol and oxytetracycline are used as treatments.
Particularly interesting results were found for resistance tests against ciprofloxacin and
kanamycin, because only two of the florfenicol-resistant isolates showed resistance for cipro-
floxacin (Table 3). But in the case of the OB a 54.5% of the bacterial isolates showed resistance
Table 3. Minimum inhibitory concentrations of florfenicol-resistant bacteria to other antibiotic families (μg/mL).
Farm Species GenBank Similarity OTC CFC TET ERY KAN CIP AMP Isolate Origin
I Pseudomonas fragi 99% 512 1024 4 128 4 2 128 13H4 F
Pseudomonas sp 99% 512 2048 256 128 8 2 256 13G1 F
Pseudomonas fragi 99% 128 2048 64 1024 8 1 512 7C5 F
Pseudomonas fragi 99% 64 2048 64 128 2 1 128 5B1 I
Pseudomonas fluorescens 99% 512 2048 64 512 8 1 512 7A3 I
Pseudomonas sp 99% 256 2048 256 64 2 1 128 4B2 F
Serratia sp 99% 512 2048 512 512 8 1 >2048 4D1 I
Pseudomonas sp 99% 64 2048 32 128 2 1 128 9A1 I
Pseudomonas azotoformans 99% 512 2048 128 256 2 1 >2048 8C2 F
Serratia sp 99% 512 64 512 256 2 1 512 9A2 I
II Serratia sp 99% 128 512 128 512 4 1 256 1B4 F
Pseudomonas fragi 99% 256 >2048 64 512 4 1 256 1E2 F
Pseudomonas fluorescens 99% 256 >2048 32 512 8 1 256 2B4 F
Pseudomonas sp 99% 32 2048 32 64 4 1 128 1D2 I
Pseudomonas fragi 99% 512 128 32 64 4 1 128 6A4 I
Pseudomonas sp 99% 128 2048 64 512 8 1 128 6C5 F
Pseudomonas sp 99% 8 256 8 1024 32 1 >2048 5B8 I
Pseudomonas fluorescens 99% 64 2048 64 512 4 1 128 6H4 I
Pseudomonas sp 100% 2 256 8 512 32 1 >2048 5C8 I
Pseudomonas fluorescens 99% 128 2048 64 1024 8 1 128 7B8 I
Pseudomonas fluorescens 99% 512 16 256 1 2 1 16 6D3 F
Pseudomonas psychrophila 99% 64 16 32 1 2 1 16 6A5 I
Pseudomonas psychrophila 99% 512 >2048 512 >2048 2048 1024 >2048 4G7 I
Pseudomonas sp 99% 2 2048 16 64 4 1 128 6H3 F
Pseudomonas sp 100% 64 256 128 512 128 1 128 4D7 F
III Pseudomonas sp 98% 4 512 4 1024 32 1 256 1A8 I
Pseudomonas sp 100% 4 512 4 1024 32 1 256 1C7 F
Pseudomonas migulae 99% 4 128 4 512 2 1 256 3C4 F
Pseudomonas fluorescens 99% 512 512 128 512 8 1 >2048 4A11 F
Pseudomonas migulae 99% 2 64 256 1024 8 1 >2048 7F11 I
Hafnia sp 99% 256 128 256 2048 8 1 128 6B1 F
Pseudomonas fragi 99% 64 2048 32 128 2 1 64 8B12 I
Pseudomonas fluorescens 99% 64 64 32 128 2 1 128 8F12 F
Pseudomonas fluorescens 99% 2 256 4 512 32 1 >2048 11H8 F
Pseudomonas sp 99% 2 64 4 1024 32 1 >2048 9F10 I
Aeromonas molluscorum 99% 2 64 4 64 8 1 >2048 9E11 I
(Continued)
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to ciprofloxacin (Table 4). Similar results were found when testing against the antibiotic kana-
mycin–only nine florfenicol-resistant bacteria evidenced a resistance phenotype against kana-
mycin (Table 3). In turn, 45.4% of those bacteria resistants to oxytetracycline were also
resistant to kanamycin, and nearly all of these bacteria originated for farm I (Table 4).
It is important to mention that only six bacterial isolates, two from the FB and four from
the OB showed resistance to the eight antibiotics evaluated. The two isolates of the FB corre-
spond to members of the Pseudomonas genus, while of the OB two of them were classified as
member of the Serratia genus and two of the Carnobacterium genus. Among the six identified
multiresistant bacteria, a Pseudomonas sp. from the FB is particularly concerning since this
bacterium presented a MIC 2,048 μg/mL to six of the eight evaluated antibiotics. Consider-
ing this finding, the assessed Psudomonas sp. isolate was termed “super-resistant” and is cur-
rently being sequenced for continued research.
Genetic determinants involved in antimicrobial resistance
After an exhaustive analysis of phenotypic resistance, a search was conducted for genetic ele-
ments directly involved in resistance to florfenicol and oxytetracycline. Integron elements
were also evaluated since these elements can collect antibiotic-resistance genes (ARGs), thus
facilitating expression [44]. These elements can not only incorporate and actively express
ARGs, because if they are incorporated in mobile genetics elements like plasmids, they can be
easily transferred also, increasing considerably the dispersion of those genes [45,46]. As
expected, FB resistant bacteria showed a high incidence of floR and fexA, genes that code for
efflux pumps from the major facilitator superfamily group MFS, that expulse a significant
number of molecules, including antibiotics, thereby conferring resistance to florfenicol. Of the
bacterial isolates with the FB, 70.2% carried floR, 46.8% carried fexA, and 34% evidenced both
genes. Only 17% did not carry either floR or fexA (Table 5). Regarding bacteria from the OB,
none carried floR. However, 52.2% did present fexA (Table 6). These results support that deter-
minants of florfenicol resistance are widely distributed across the gut microbiota of farmed
fish as a result of high antibiotics administration.
After assessing the presence of florfenicol-resistance genes among the FB and OB isolates,
analyses were conducted for genes connected to oxytetracycline resistance. Eight resistance
genes were included in evaluations, all of which confer resistance to the tetracycline drug
Table 3. (Continued)
Farm Species GenBank Similarity OTC CFC TET ERY KAN CIP AMP Isolate Origin
IV Pseudomonas jessenii 99% 16 1024 16 512 4 1 256 1G10 I
Pseudomonas sp 99% 32 2048 32 128 4 2 128 1H11 F
Pseudomonas sp 99% 32 >2048 32 256 0 1 256 1F11 F
Pseudomonas sp 99% 4 128 4 512 4 1 256 3A8 F
Pseudomonas fragi 99% 64 2048 64 512 8 1 128 5B4 I
Pseudomonas sp 99% 512 >2048 512 >2048 >2048 2048 >2048 4C3 F
Pseudomonas sp 99% 2 64 4 512 2 1 >2048 10G1 F
Pseudomonas sp 99% 32 64 8 32 1 1 64 8A7 I
Pseudomonas sp 99% 16 256 4 16 1 1 256 9B4 I
Pseudomonas sp 99% 2 64 4 1024 2 1 >2048 9C6 F
AMP (ampiciline), CHL (chloramphenicol), CIP (ciprofloxacin), ERY (erythromycin), OTC (Oxytetracycline), KAN (kanamycin), TET (tetracycline). As a control was
used the strain E. coli K12. Resistance levels was defined by the EUCAST values for any antibiotic. AMP64 μg/ml, CHL32 μg/ml, CIP4, ERY16 μg/ml, KAN
16 μg/ml, TET32 μg/ml. Origin: F = Fecal matter; I: Intestine
https://doi.org/10.1371/journal.pone.0203641.t003
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Table 4. Minimum inhibitory concentrations of oxytetracycline -resistant bacteria to other antibiotic families (μg/mL).
Farm Species GenBank Similarity FLO CFC TET ERY KAN CIP AMP Isolate Origin
I Serratia proteamaculans 96% 2048 2048 1024 512 128 8 2 P151C9 I
Serratia proteamaculans 96% 2048 2048 1024 512 128 8 4 P151E2 I
Serratia proteamaculans 98% 512 2048 1024 512 128 8 2 25P1E12 F
Serratia proteamaculans 99% 512 512 512 512 128 8 2 30P1XC9 I
Serratia proteamaculans 99% 512 512 512 1024 1024 512 2048 30P1XC8 I
Serratia proteamaculans 99% 512 512 256 128 512 8 1024 30P1XD3 I
Serratia proteamaculans 99% 512 512 512 256 512 8 2 30PF8 F
Serratia proteamaculans 99% 512 512 256 128 512 8 32 30PF10 I
Serratia proteamaculans 99% 512 512 256 128 512 8 32 30PF11 I
Serratia proteamaculans 98% 512 512 512 128 512 8 2 30P1XE10 I
Pseudomonas fragi 99% 512 512 256 128 512 8 2 30P1XB10 F
Pseudomonas fragi 100% 1024 512 256 64 32 8 32 25P1H2 I
Pseudomonas fragi 100% 512 512 256 32 512 8 2 P30F12 I
Pseudomonas fragi 100% 1024 1024 512 512 1024 512 32 25P1D4 I
Pseudomonas fragi 98% 512 512 256 128 512 8 2 30P1XE12 F
Shewanella baltica 96% 16 16 64 128 32 8 2 30P1XB8 F
Hafnia alvei 99% 1024 1024 32 128 1024 8 2 25P3D1 I
Rouxiella chamberiensis 99% 512 512 256 128 32 8 32 30PXG6 I
II Rouxiella chamberiensis 99% 2048 1024 256 32 8 2 128 154F5 F
Carnobacterium maltaromaticum 100% 1024 1024 512 1024 512 2048 >2048 25P2A9 F
Brochothrix thermosphacta 97% 512 256 64 512 8 2 128 P30XA10 F
Brochothrix thermosphacta 97% 512 256 128 32 8 2 128 P30XB10 I
Rouxiella chamberiensis 100% 512 256 128 32 8 2 256 30PXB9 F
Rahnella sp. 99% 256 256 128 32 8 2 256 30PXG7 I
Rouxiella chamberiensis 99% 256 256 64 512 8 2 128 P30XB3 F
Carnobacterium maltaromaticum 100% 512 256 64 512 8 2 128 P30XD4 F
Carnobacterium maltaromaticum 100% 256 256 64 512 8 2 128 P30XD5 I
Carnobacterium maltaromaticum 100% 512 256 128 32 512 16 128 P30XG8 F
III Serratia proteamaculans 98% 1024 512 512 128 8 32 256 25P1F12 F
Brochothrix thermosphacta 100% 512 32 128 32 8 2 64 25P3C5 I
Brochothrix thermosphacta 100% 512 256 128 512 8 2 64 30P1XG3 F
Brochothrix thermosphacta 100% 256 256 64 32 8 2 64 P30C3 I
Brochothrix thermosphacta 100% 512 256 64 32 8 2 64 P30C4 I
Brochothrix thermosphacta 100% 512 256 64 32 8 2 64 P30C5 I
Shewanella hafniensis 99% 256 256 64 512 8 2 64 30PF3 F
IV Shewnella vesiculosa 99% 256 64 16 64 8 2 64 15P2G11 F
Shewanella putrefaciens 99% 64 32 128 64 8 2 64 25P3F1 I
Shewanella putrefaciens 99% 2048 256 128 128 8 4 128 15P3A4 F
Kluyvera intermedia 94% 2048 1024 256 128 8 2 128 15P2D11 F
Kluyvera intermedia 99% 2048 1024 256 128 8 2 128 15P2G8 I
Psychrobacter nivimaris 99% 256 256 16 64 8 4 64 15P2H7 F
Pseudomonas baetica 99% 256 32 32 1024 8 2 512 25P2F9 I
Pseudomonas fragi 98% 256 512 256 128 8 2048 64 25P2F4 F
Aeromonas salmonicida 95% 512 32 32 64 8 2 64 30PB8 F
Antibiotic used, AMP (ampiciline), CHL (chloramphenicol), CIP (ciprofloxacin), ERY (erythromycin), FLO (florfenicol), KAN (kanamycin), TET (tetracycline). As a
control was used the strain E. coli K12. Resistance levels was defined by the EUCAST values for any antibiotic. AMP64 μg/ml, CHL32 μg/ml, CIP4, ERY16 μg/
ml, KAN16 μg/ml, TET32 μg/ml. Origin: F = Fecal matter; I: Intestine
https://doi.org/10.1371/journal.pone.0203641.t004
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Table 5. Antibiotic resistance genes amplified by PCR and sequenced in bacteria resistant to florfenicol.
Farm Species floR fexA tet34 tet35 tetA tetB tetE tetH tetL tetM int1 Isolate Origin
I Pseudomonas fragi - + - - - - - - - + + 13H4 F
Pseudomonas sp - + - - + - - - - - + 13G1 F
Pseudomonas fragi + + - - - - - + + - + 7C5 F
Pseudomonas fragi + + - - - - + + + - + 5B1 I
Pseudomonas fluorescens + + - - - - - + + - + 7A3 I
Pseudomonas sp + - - - + - + + - - - 4B2 F
Serratia sp + + - - + - - - - - + 4D1 I
Pseudomonas sp + - - - - - - + - - + 9A1 I
Pseudomonas azotoformans + + - - - - - + - - + 8C2 F
Serratia sp + + - - - - + + - - + 9A2 I
II Serratia sp + - - - - + - + - - + 1B4 F
Pseudomonas fragi - - - - - + - + - - + 1E2 F
Pseudomonas fluorescens + + - - - - - + + + + 2B4 F
Pseudomonas sp + - - - - - - + - - + 1D2 I
Pseudomonas fragi + - - - - - + - - - + 6A4 I
Pseudomonas sp + + - - - - - + + - + 6C5 F
Pseudomonas sp + - - - - - - - - - + 5B8 I
Pseudomonas fluorescens + + - - - - - - - - + 6H4 I
Pseudomonas sp - - - - - - - - - - + 5C8 I
Pseudomonas fluorescens + + - - - - - + - - + 7B8 I
Pseudomonas fluorescens + - - - - - - - - + + 6D3 F
Pseudomonas psychrophila + + - - - - - - + - + 6A5 I
Pseudomonas psychrophila + - - - - - - - - - + 4G7 I
Pseudomonas sp - + - - - - - - + - + 6H3 F
Pseudomonas sp + - - - - - - + - + + 4D7 F
III Pseudomonas sp + - - - - - - - - - + 1A8 I
Pseudomonas sp - - - - - - - - - - + 1C7 F
Pseudomonas migulae - - - - - - + - - - + 3C4 F
Pseudomonas fluorescens + + - - - - + + - + + 4A11 F
Pseudomonas migulae + + - - + - - - - - + 7F11 I
Hafnia sp + - - - + - + - - - - 6B1 F
Pseudomonas fragi - - - - - - - + - - + 8B12 I
Pseudomonas fluorescens + + - - - - - + - - + 8F12 F
Pseudomonas fluorescens - - - - - - - - + - + 11H8 F
Pseudomonas sp + + - - - - - - - - + 9F10 I
Aeromonas molluscorum ND + - - - - - - - - + 9E11 I
IV Pseudomonas jessenii + - - - - - - + - - + 1G10 I
Pseudomonas sp + - - - + - + + - - + 1H11 F
Pseudomonas sp + - - - + - - + - - + 1F11 F
Pseudomonas sp - - - - - - + - - - + 3A8 F
Pseudomonas fragi + + - - - - - + + - + 5B4 I
Pseudomonas sp - + - - - - - + - + + 4C3 F
Pseudomonas sp - - - - - - - - - - + 10G1 F
Pseudomonas sp + - - - - - - - + - + 8A7 I
Pseudomonas sp ND - - - + - + + + - - 9B4 I
Pseudomonas sp + + - - - - - - - - + 9C6 F
(+) Presence of the gene; (-) Absence of the gene; (ND) Not Determined.
https://doi.org/10.1371/journal.pone.0203641.t005
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Table 6. Antibiotic resistance genes amplified by PCR and sequenced in bacteria resistant to oxytetracycline.
Farm Species floR fexA tet34 tet35 tetA tetB tetE tetH tetL tetM Int1 Isolate Origin
I Serratia proteamaculans - - - + + + - - + + + P151C9 I
Serratia proteamaculans - - - - - + - - + + + P151E2 I
Serratia proteamaculans - - - + - + + - - + + 25P1E12 F
Serratia proteamaculans - - - - - + + - + + + 30P1XC9 I
Serratia proteamaculans - - - - - + + - + - + 30P1XC8 I
Serratia proteamaculans - + - - + + + - + - + 30P1XD3 I
Serratia proteamaculans - + - - - + + - + + + 30PF8 F
Serratia proteamaculans - + - - - + + - + + + 30PF10 I
Serratia proteamaculans - + - - - + + - + - + 30PF11 I
Serratia proteamaculans - - - - - + + - + - + 30P1XE10 I
Pseudomonas fragi - + - + + + - + - + + 30P1XB10 F
Pseudomonas fragi - - - + + - - + + + + 25P1H2 I
Pseudomonas fragi - + + - + - - - - + + P30F12 I
Pseudomonas fragi - - - + + - - + - - + 25P1D4 I
Pseudomonas fragi - + - - + - - - - + + 30P1XE12 F
Shewanella baltica - + - - - + - - + + + 30P1XB8 F
Hafnia alvei - - - - - - - - - + + 25P3D1 I
Rouxiella chamberiensis - + - - - + - + + + + 30PXG6 I
II Rouxiella chamberiensis - - - - + - + - - + + 154F5 F
Carnobacterium maltaromaticum - - - - - - - - + + + 25P2A9 F
Brochothrix thermosphacta - + - - - - + - + + + P30XA10 F
Brochothrix thermosphacta - + - - - - - - + + + P30XB10 I
Rouxiella chamberiensis - + - - - - - + + + + 30PXB9 F
Rahnella sp. - + + - - - - + + + + 30PXF7 I
Rouxiella chamberiensis - + - - - - - + + + + P30XB3 F
Carnobacterium maltaromaticum - + - - + - + - + + + P30XD4 F
Carnobacterium maltaromaticum - + - - - + - - + + + P30XD5 I
Carnobacterium maltaromaticum - + - - - - + - + - + P30XG8 F
III Serratia proteamaculans - - - - + + + - + + + 25P1F12 F
Brochothrix thermosphacta - + - - + - - - + + + 25P3C5 I
Brochothrix thermosphacta - ND - - + - - - + + + 30P1XG3 F
Brochothrix thermosphacta - + - - - - - - + + + P30C3 I
Brochothrix thermosphacta - + - - - - - + + + + P30C4 I
Brochothrix thermosphacta - ND - - - - + - + + + P30C5 I
Shewanella hafniensis - + - + - + + + + + + 30PF3 F
IV Shewnella vesiculosa - + - - - + - - - - + 15P2G11 F
Shewanella putrefaciens - + - - - + + - - - + 25P3F1 I
Shewanella putrefaciens - - - + - + - - - + + 15P3A4 F
Kluyvera intermedia - + - - - - + - - - + 15P2D11 F
Kluyvera intermedia - - - + - - + - - + + 15P2G8 I
Psychrobacter nivimaris - ND - - + - - - + - + 15P2H7 F
Pseudomonas baetica - - - + + + + + - + + 25P2F9 I
Pseudomonas fragi - - - - - - + - - - + 25P2F4 F
Aeromonas salmonicida - ND - - + + + - + - + 30PB8 F
(+) Presence of the gene; (-) Absence of the gene; (ND) Not Determined.
https://doi.org/10.1371/journal.pone.0203641.t006
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family. These apply named tet genes included tetA, tetB, tetE, tetH, tetL, tet34, and tet 35, all of
which were previously described in sediments associated with salmon farms [43], but not with
intestinal microbiota of the farmed fish. The presence of tetM was also included considering
prior reports of being a widely dispersed and prevalent resistance mechanism against tetracy-
clines [47,48]. For OB resistance bacteria, 100% of isoaltes presented at least one of the evalu-
ated tet genes, the more prevalent of which was, not surprisingly, tetM (72.7%). Following in
prevalence was tetL (68.1%). Among this group of bacterial isolates, 4.5% of the bacterial iso-
lates carried six tet genes, 9,1% five and 15.9% four. In other words, 29.5% of oxytetracycline-
resistant bacteria carried at least four different resistance genes to this antibiotic (Table 6).
Regarding those bacteria included in the FB, 78.7% of isolates had at least one of the evaluate
tet genes, 48.9% of which were carries of tetH (i.e., the most abundant in florfenicol-resistant
bacteria; Table 5). Likewise, an estimated 12.8% of the FB isolates carried at least three of the
evaluated tet genes. The presence of specific ARGs against florfenicol and oxytetracycline cor-
roborate the phenotypic resistances observed for each of the resistant isolates. Further research
is needed regarding those resistant isolates for which no ARGs were detected. To understand
these results, it is necessary to take into account the limitations of detection using the PCR
technique, since only eight out of 28 tet genes were evaluated [49], the most frequently
described in aquaculture [50]. The same happens with the genes of resistance to phenicoles
since only those that are detected more frequently at environmental level were evaluated
[38,51]. Therefore a metagenomic analysis would be very useful to detect all the possible genes
involved in the resistance against these antibiotics.
Once resistance elements to the most widely used antibiotics were determined, a search for
integron-like elements was conducted. The presence of type I integrase was established
through PCR analyses and posterior sequencing. In the case of OB isolates, 100% were positive
for type I integrase, while 96% of FB isolates presented type I integrase (Tables 5 and 6). These
results suggest that this type of element might be widely distributed among resistant bacteria
residing within the gut microbiota of fish. These are highly dangerous elements that play a fun-
damental role in the distribution and phenotypic expression of ARGs. A dedicated study on
the detected integrons is currently underway in our lab.
Taxonomic differences among bacteria resistant to florfenicol and
oxytetracycline
In contrast to previously published reports, the present study simultaneously provides informa-
tion related to the phenomena of resistance to florfenicol and oxytetracycline, with the different
tested isolates having been directly obtained from the intestinal microbiota of farmed salmon
exposed to high concentrations of antibiotics. Of note, the conducted analyses detected differences
in species richness for resistant bacteria. More specifically, the FB isolates evidenced a high pre-
dominance of Pseudomonas species, a phenomenon that was found across the sampled farming
centers and among all the evaluated temperatures. To a lesser degree, members of the Gammapro-
tebacteria class were also isolated, including Aeromonas, Serratia, and Hafnia species. Regarding
OB isolates, a high incidence of Gammaprotebacteria were also observed, as represented by the
genera Serratia, Hafnia, Rouxiella, Rahnella, Kluyvera, Shewanella, psychrobacter, Aeromonas, and
Pseudomonas. Furthermore, Gram-positive bacteria were represented by the Firmicutes phylum,
notable among which were Carnobacterium and Brochothrix, among others.
Discussion
Antibiotic use in the production of animal proteins is a practice that should be controlled on a
global scale, specifically since the application of these medicines for veterinary ends many
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times lacks the degree of strict control imposed on human medicines. One of the primary
methods for administering antibiotics to industrially farmed animals is medicated feed [52–
54]. This delivery method is the most popular among farmed fish due to the notable technical
difficulties associated with administering antibiotics through other means, such as injection
[55,56]. The ingestion of medicated feed implicates that the intestinal microbiota of these ani-
mals is strongly affected. Antibiotics substantially change the bacterial diversity of gut micro-
biota in farmed animals [53], which, often, can result in functional and growth problems [57].
Another effect caused by the high use of the medicated food on the intestinal microbiota is
that the feces could contain resistant bacteria, which could be easily dispersed in the environ-
ment [58,59]. In this work it was possible to demonstrate that the feces contain multiresistant
bacteria, which are constantly being released into the environment. Additionally, it was
observed that the diversity of resistant isolates is similar to that found in the intestine, reaffirm-
ing in this way that eventually any resistant bacteria selected in the intestine carrying ARGs
could be disseminated through the feces.
Various studies have extensively characterized the gut-microbiota composition of Atlantic
salmon, reporting total dominance by the Proteobacteria phylum. More specific still, Pseudo-
monas species of the Gammaproteobacteria class are the most represented [29,60]. These prior
descriptions were supported by the present study, with most of the resistant isolates being of
the Pseudomonas genus. Prior research has similarly characterized the effect that oxytetracy-
cline use has on the microbiota composition of Atlantic salmon. For example, Navarrete et al.
(2008) [29] exposed Atlantic salmon to high oxytetracycline concentrations under experimen-
tal conditions (i.e., not in the field) and found a notable enrichment of Aeromonas salmonicida,
a bacterial pathogen. In the present study, only one Aeromonas isolate was found in the OB
group, thus corroborating the possible selection of this bacterium under high oxytetracycline
concentrations.
A fundamental finding of the present study is that oxytetracycline-resistant isolates were
found to be more diverse than those resistant to florfenicol. This could have direct implications
on treatments and the strategies applied to the use of these antibiotics. Since the early report of
P. salmonis infection by the end of the 80s, oxytetracycline and quinolones have been used to
tackle the infection. Also, oxytetracycline is the most widely used antibiotic during freshwater
rearing, with florfenicol use nearly null during this stage [25]. Consequently, the large majority
of farmed fish with a freshwater stage have been subjected to oxytetracycline treatments [25].
This could, in turn, mean that the gut microbiota of these fish is already rich in bacteria resis-
tant to oxytetracycline. Little research has reported on substantial changes to the microbiota of
freshwater- versus seawater-stage salmon. However, some authors speculate that a large part of
the microbiota would be conserved between systems [61]. In contrast to freshwater farming,
florfenicol is the most widely used antibiotic in seawater farming. Supporting this claim, all of
the currently assessed fish farms had applied three to four oral applications of florfenicol, and
only farm I had used an additional treatment of oxytetracycline at the time of sampling. This
might explain the lesser diversity of bacteria resistant to florfenicol; i.e., the constant florfenicol
treatments may have selected and maintained only those bacteria with the most efficient mech-
anisms against this antibiotic. This is the perfect scenario for Pseudomonas members, the
genomes of which are equipped with multiple resistance elements that make these bacteria
competitive in environments saturated with antibiotics [62,63].
In addition to the well-known antibiotic resistance capacity of Pseudomonas, the present
study detected most of the resistance genes included in assessments, and the majority of these
genes, excepting tetM, were drug efflux pumps. These findings corroborate that these genetic
elements are a principal trait of Pseudomonas bacteria [64]. Considering the phenotypic versa-
tility of Pseudomonas, it was unsurprising that the majority of the obtained florfenicol-resistant
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isolates were of this genus. Regarding oxytetracycline-resistant isolates, the detected genera, as
with Pseudomonas, are highly ubiquitous in different systems. For example, Hafnia alvei has
been isolated from the intestinal microbiota of various organisms, including pigs, cows, and
fish [65,66]. This bacterium is an important contaminant of packaged food [67], meaning that
H. alvei is an ideal resistant-isolate candidate in any system. These traits can also be found in
species of Shewanella [68,69], Serratia [70,71], Carnobacterium [72], Brochotrhix [73,74], and
Kluyvera [75,76]. All of these bacteria can colonize multiple environments, and the ability to
acquire resistance in any given environment represents a significant risk for human health.
Only Aeromonas molluscorum [77,78] and Psychrobacter nivimaris [79] are exclusive to the
aquatic environment, which translates into a highly probable exchange of ARGs between bac-
teria directly related to the human system and environmental bacteria from the gut microbiota
of fish.
Tetracyclines are commonly used in veterinary medicine around the world, and, specifi-
cally, oxytetracycline is the most widely used antibiotic during the freshwater stage of salmon
growth in Chile [25]. Origin records for the Atlantic salmon sampled in the present study were
not obtained, but it is very likely that the sampled fish were exposed to high doses of oxytetra-
cycline during the freshwater stage. This would explain the high instance of oxytetracycline-
resistant bacteria, even when oxytetracycline was not applied during the seawater stage. Simi-
larly, the high prevalence of tet genes found for the FB and OB could be explained by the high
frequency at which these genes localize in mobile genetic elements, such as plasmids or trans-
posons [49]. The genes tetA, tetB, tetE, tetL, tetH, tet34, and tet35 have been recorded in the
sediments and water column of Chilean salmon farms [43,80]. An interisting case is the gene
tetM, this globally distributed gene presents a clinically confirmed resistance mechanism to tet-
racyclines [81,82]. One trait of this gene is that it is frequently associated with transposons and
plasmids in human pathogenic bacteria [83,84]; this could be a clear sign of the impacts this
gene is having from the clinical to the environmental spheres. Consequently, antibiotics used
in industrially farmed animals could substantially contribute to the maintenance and disper-
sion of ARGs in natural environments.
As with the tet genes, the presence of floR, a drug efflux pump of the major facilitator super-
family (MFS), has previously been reported in bacteria collected from marine sediments asso-
ciated with salmon farming in Chile [39]. This gene has even been detected in a plasmid that
also transported tet and qnr genes, the latter of which are implicated in resistance to quino-
lones [85]. However, the present study is the first to report on the existence of floR in the gut
microbiota of salmon. Furthermore, this investigation is the first to find and report on fexA, an
efflux pump of the major facilitator superfamily also, in association with Chilean salmon farm-
ing, with no previously published study having detected this gene in relation to the Chilean
aquaculture industry. This fenicol-resistance gene was first described in the bacterium Staphy-
lococcus lentus [40], and has since almost been exclusively described in members of the Staphy-
lococcus genus [41,42,51,86–88], both for humans and animals, but never in the marine
environment. Apart from the Staphylococcus genus, fexA has been described in members of
the Enterococcus genus, specifically in association with industrially farmed terrestrial animals
[89,90]. No Staphylococcus or Enterococcus bacteria were found among any of the obtained
resistant isolates, but the presented findings do support the ability of fexA to disperse across a
wide variety of both Gram-positive and–negative bacteria.
One curious outcome of the conducted study was that none of the oxytetracycline-resistant
bacteria presented floR, but, by contrast, 52,2% did present fexA. As mentioned, the most
widely used antibiotic used in Chilean salmon farming is oxytetracycline, and there is a nearly
null use of florfenicol in the freshwater stage. Prior reports have found fexA in plasmids con-
taining a great number of resistance genes to other antibiotics [87]. Therefore, this gene has
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probably been selected during the freshwater stage in plasmids that also carry tetracylcin-resis-
tance genes. This co-selection is likely since the water used in the freshwater rearing stage is
collected from the lakes and rivers most exposed to human activities, including livestock
farms, and, as stated, fexA has almost exclusively been isolated from industrially farmed terres-
trial animals. This is another compelling case for ARGs primarily originating from human
activities and not directly from salmon farming.
In contrast to findings from sediments related to intense salmon farming in Chile [91], the
present study found a high incidence of class I integrons in resistant isolates from both the FB
and OB databases. In fact, 100% of OB isolates and 96% of FB isolates were positive for type I
integrase. These genetic elements are the greatest contributors to the evolution and dispersion
of ARGs [92]. Integrons are true genetic platforms that acquire exogenous genes through
mobile genetic cassettes, having the ability to collect up to hundreds of genes in the same unit
[93]. Nevertheless, these elements did not originate in bacterial pathogens, nor is their primary
function to collect antibiotic-resistance genes. Integrons frequently appear in Betaproteobac-
teria native to soils, freshwater, and saltwater. Genetic cassettes are incorporated alongside ele-
ments that are highly varied and much more diverse than ARGs [94]. Integrons are very
successful and ubiquitous in natural environments, and it is therefore unsurprising that the
majority of the isolated OB and FB bacteria would present these elements. Concern arises
when these elements have a clinical origin and carry ARGs for most of the known antibiotics
[95]. Integrons carrying ARGs against quinolones (qnrA and qnrB), trimethoprims (drfA12),
and aminoglycosides (aad2) have recently been described in the Chilean farming system,
which is in addition to some clinical Escherichia coli also carrying these plasmid-transferred
integrons [96]. This appears to be credible proof that there is an interaction between the clini-
cal environment and that of salmon farming. However, a number of questions remain–What
is the origin of these integrons? Are they from aquaculture-associated bacteria? Or have contri-
butions from the clinical environment contaminated bacteria from salmon farming? These
questions need to be answered. No integron from either the OB or FB bacteria presented the
traits described by Tomova et al. (2018) [90].
Another important aspect to consider in this work is the Antibiotic Resistance Rate (ARR).
Overall, it was found that less than 1% of the total bacterial isolates were resistant to oxytetra-
cycline or florfenicol (0.94% for florfenicol and 0.87% for oxytetracycline). Although there are
few works in which this rate is addressed at an environmental level [97,98], values close to 1%
can be considered high [97–100]. In these works it can be seen that when the concentration of
antibiotics in the medium increases, the value of this range increases too. This phenomenon is
corroborated in the present work since the ARR in the FB for farm II exceeds 1%, almost twice
as much as that presented by the other farms and it is precisely the farm II that the major num-
ber of treatments with florfenicol presents, four. The same effect is observed in the OB in farm
I where ARR again exceeds 1% and the farm I is the only one that uses oxytetracycline as a
treatment in its seawater stage.
The information collected in the present study clearly indicate that using large amounts of
antibiotics to treat industrially farmed animals has the consequence of selecting for multiresis-
tant bacteria in the intestinal microbiota, which then have undeniable advantages when liber-
ated into the environment through the feces. While the obtained results are somewhat biased
towards “culturable” bacteria, metagenomics data are currently being analyzed, the results of
which will reveal all of the bacteria that did not grow in a TSA medium. This information will
provide a complete picture for the behaviors of the bacterial populations interacting in this
complex system. Meanwhile, the currently reported data do show that the intestinal micro-
biota, as a system “semi-isolated” from the environment yet in direct contact with applied anti-
biotics, is the perfect place for interactions to occur between bacteria from different
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environments, including from the human clinical context. Therefore, the gut microbiota of
farmed salmon could also serve as the perfect reservoir for ARGs, the dispersion of which
would be fundamentally related to feces. The release of feces with resistant bacteria and ARGs
is creating an environment constantly rich in resistance elements, creating an ideal situation
for genetic exchanges to occur between different bacterial populations, whether in the water
column or in marine sediments. These populations are precisely where fish pathogens can be
found, thus notably increasing the risk that these bacteria will acquire resistance elements. If
this occurs, no effective treatments will exist for the control of these pathogens. Fortunately, a
number of aquaculture producers are beginning to understand the gravity of the situation.
Measures aimed at decreasing antibiotic usage are increasingly being adopted, with expecta-
tions that by 2020, there will be at least a 50% decrease in the use of these substances.
Conclusion
In this study, bacterial isolates from fish gut microbiota of the Salmo salar species, showing
high resistance levels to antibiotics oxytetracycline and florfenicol, were characterised. The
feces, represent important vehicles of dispersion of resistant bacteria and ARGs. The analyses
showed that the high use of these antibiotics selects bacteria that are multiresistant to a wide
range of antibiotics. In turn, these bacteria show a high prevalence of antibiotic resistance
genes, thus, verifying the phenotypic resistance with the mechanism present in the bacteria to
cope with these substances. Furthermore, almost 100% of these (antibiotic) resistant isolates
showed class 1 integrons, dangerous elements involved in the resistance phenomenon due to
their capacity of dispersion.
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